MartaACrispensMD
Obstetrics & Gynecology • Nashville, TNGynecologic Oncology
Assistant Professor of Obstetrics & Gynecology, Vanderbilt University
Dr. Crispens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1995 - 1998
University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 1991 - 1995
University of Alabama School of MedicineClass of 1991
Certifications & Licensure
TN State Medical License 2002 - 2027
AL State Medical License 1993 - 2020
IL State Medical License 1998 - 2005
TX State Medical License 1996 - 2003- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Nashville Lifestyles Magazine Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer Start of enrollment: 2006 Nov 01
- SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin Start of enrollment: 2010 Jul 01
- Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers Start of enrollment: 2020 Oct 01
Publications & Presentations
PubMed
- Randomized phase II study of bevacizumab with weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant/refractory high grade ovarian cancer (NCI trial).Husam A Alqaisi, David E Cohn, Jing-Yi Chern, Linda R Duska, Andrea Jewell
Clinical Cancer Research. 2025-01-21 - 11 citationsVulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.Nadeem R Abu-Rustum, Catheryn M Yashar, Rebecca Arend, Emma Barber, Kristin Bradley
Journal of the National Comprehensive Cancer Network. 2024-03-01 - Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift.Mohammed N Tantawy, J Oliver McIntyre, Fiona Yull, M Wade Calcutt, Dmitry S Koktysh
Cancer Medicine. 2024-02-01
Press Mentions
Berlin Assumes New VICC Leadership PostMay 29th, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
